Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
periodontitis pharyngitis gingivitis amalgam fluoride mutans pulp candidiasis pulp malocclusionYour Article Summary
See Latest ArticlesSerum soluble CD44v6 levels in patients with oral and maxillofacial malignancy
Oral Diseases , 07/01/09
Chang SM et al. - In a trial to determine the levels of serum sCD44v6 in pts with oral cancer and evaluate the value of serum sCD44v6 in adjuvant diagnosis, staging, and monitoring treatment response in these pts, it was concluded that the possible roles of CD44v6 in diagnosis of oral and maxillofacial malignancy deserve further elucidation and evaluation. Serum sCD44v6 may be a valuable marker in monitoring treatment response in pts with OSCC.
Methods- 112 hospitalized pts with oral and maxillofacial malignancy and 28 healthy individuals were examined for serum sCD44v6 levels.
- Venous blood was collected from pts and healthy individuals.
- 1 wk after treatment, venous blood was collected once again in 60 pts with oral and maxillofacial squamous cell carcinoma (OSCC).
- The sCD44v6 concentration was not significantly different between pts with oral and maxillofacial malignancy and control group.
- Levels of serum sCD44v6 in pts with OSCC and salivary carcinoma showed no difference with those in control group.
- sCD44v6 level in pts with stage III and IV disease was higher than that of pts with stage I and II and that of the control group, but the difference was not significant.
- Serum sCD44v6 levels in pts with OSCC after treatment became lower than that prevailed during pretreatment.
Today in OMF Pathology...keeping you current
Receive free subspecialty "5-minute updates" via email
Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD
Bone Marrow Transplantation, 11/05/09
Oral Cancer Prevention Advances with a Translational Trial of Green Tea
Cancer Prevention Research, 11/10/09
Autofluorescence-Guided Surveillance for Oral Cancer
Cancer Prevention Research, 11/10/09
Today in OMF Surgery...keeping you current
Receive free subspecialty "5-minute updates" via email
ECG variations in patients pre- and post-local anaesthesia and analgesia
British Dental Journal , 11/09/09
Radiosurgical treatment of maxillary squamous cell carcinoma
International Journal of Oral and Maxillofacial Surgery, 10/30/09
The effect of quitting smoking on the risk of unfavorable events after surgical treatment of oral potentially malignant lesions
International Journal of Oral and Maxillofacial Surgery, 10/29/09
Article Search
Sponsor